Design, synthesis, and evaluation of novel Indole‐Based small molecules as sirtuin inhibitors with anticancer activities
Drug Development Research · 2024
DOI: 10.1002/ddr.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Busra Binarci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, METU, Ankara, Turkiye. Hauptthemen laut MEDLINE: Indoles, Antineoplastic Agents, Drug Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Turkish Ministry of Strategy and Budget.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide, driven mainly by chronic hepatitis infections and metabolic disorders, which highlights the urgent need for novel therapeutic strategies. Sirtuins, particularly SIRT1 are crucial in HCC pathogenesis, making it a promising drug target. Indole‐based molecules show potential as therapeutic agents by interacting with key proteins like sirtuins involved in cancer progression. In this study, we designed and synthesized novel indole‐based small molecules and investigated their potential sirtuin inhibitory action and anticancer activity on HCC cell lines. Four of the twenty‐eight tested small molecules on different cancer types were selected ( 4 g , 4 h , 4o , and 7j ) based on their structure–activity relationship and studied on a panel of HCC cell lines. Compounds had active drug‐target interactions with SIRT1 or SIRT2 based on DEEPScreen DTI predictions and docking studies which confirmed that 4o , 4 g , and 7j were most potent in their interaction with SIRT1. Compound 4 g caused the highest sirtuin activity inhibition in vitro and induced G1 arrest and apoptosis in HCC cell lines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, METU, Ankara, Turkiye.
- Division of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.
- Biological Data Science Lab, Department of Computer Engineering, Hacettepe University, Ankara, Turkiye.
- Department of Bioinformatics, Graduate School of Health Sciences, Hacettepe University, Ankara, Turkiye.
- Cancer Systems Biology Laboratory, Department of Health Informatics, Graduate School of Informatics, METU, Ankara, Turkiye.
- Department of Pharmaceutical Chemistry, Graduate School of Health Sciences, Gazi University, Ankara, Turkiye.
ORCID-Profile: Deniz Cansen Kahraman, Sultan Nacak Baytas
Förderung
- Turkish Ministry of Strategy and Budget
Zitieren
APA
Binarci, B., Kilic, E. K., Dogan, T., Cetin Atalay, R., Kahraman, D. C., & Nacak Baytas, S. (2024). Design, synthesis, and evaluation of novel Indole‐Based small molecules as sirtuin inhibitors with anticancer activities. Drug Development Research. https://doi.org/10.1002/ddr.70008
Vancouver
Binarci B, Kilic EK, Dogan T, Cetin Atalay R, Kahraman DC, Nacak Baytas S. Design, synthesis, and evaluation of novel Indole‐Based small molecules as sirtuin inhibitors with anticancer activities. Drug Development Research. 2024. doi:10.1002/ddr.70008
BibTeX
@article{Binarci2024,
author = {Binarci, Busra and Kilic, Ensar Korkut and Dogan, Tunca and Cetin Atalay, Rengul and Kahraman, Deniz Cansen and Nacak Baytas, Sultan},
title = {Design, synthesis, and evaluation of novel Indole‐Based small molecules as sirtuin inhibitors with anticancer activities},
journal = {Drug Development Research},
year = {2024},
doi = {10.1002/ddr.70008}
}
EUVIMED